PASSAMONTI, FRANCESCO

PASSAMONTI, FRANCESCO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 136 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Prognostic and Predictive Models in Myelofibrosis 2024 Cattaneo, DanieleVersino, FrancescoPassamonti, Francesco + Article (author) -
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases 2024 Cattaneo, DanieleMarchetti, AlfredoGalli, NicoleLionetti, MartaGianelli, UmbertoPassamonti, FrancescoBolli, Niccolò + Article (author) -
Circulating biomarkers in familial cerebral cavernous malformation 2024 Lanfranconi, SilviaTassi, LauraLeone, RobertoBolli, NiccoloPassamonti, Francesco + Article (author) -
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib 2024 Cattaneo, DanieleGalli, NicoleFidanza, Cecilia AnnaPassamonti, Francesco + Article (author) -
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers 2024 Ronchetti, DomenicaTraini, ValentinaSilvestris, IlariaPassamonti, FrancescoBolli, NiccoloTaiana, Elisa + Article (author) -
Deciphering molecular complexity of HCV-associated lymphoproliferation 2023 Passamonti F. + Article (author) -
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 2023 Bolli, Niccolo'Rambaldi, AlessandroPassamonti, Francesco + Article (author) -
Early treatment for COVID-19 in patients with haematological malignancies: Much more than a recommendation! 2023 Passamonti, FrancescoBandera, Alessandra Article (author) -
SOHO State of the Art Updates and Next Questions | Polycythemia Vera: Is It Time to Rethink Treatment? 2023 Passamonti, Francesco + Article (author) -
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 2023 Mancini, AlessandroCorradini, PaoloPassamonti, Francesco + Article (author) -
COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA) 2023 Farina, FrancescaCorradini, PaoloPassamonti, Francesco + Article (author) -
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 2023 Derenzini, EnricoFederici, Augusto BramanteGuidetti, AnnaCorradini, PaoloPassamonti, Francesco + Article (author) -
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis 2023 Francesco Passamonti + Article (author) -
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies 2023 Cattaneo, DanielePassamonti, Francesco + Article (author) -
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 2022 Passamonti F. + Article (author) -
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib 2022 Passamonti F. + Article (author) -
Defining disease modification in myelofibrosis in the era of targeted therapy 2022 Passamonti F. + Article (author) -
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 2022 Finazzi M. C.Rambaldi A.Passamonti F. + Article (author) -
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study 2022 Marasco, VincenzoGuidetti, AnnaTurrini, MauroTucci, AlessandraLuppi, MarioPassamonti, FrancescoCorradini, Paolo + Article (author) -
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey 2022 Guidetti, AnnaPassamonti, FrancescoCorradini, Paolo + Article (author) -